These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6539968)

  • 1. Comparison of methylprednisolone and metoclopramide in the prophylactic treatment of cis-platin-induced nausea and vomiting.
    Giaccone G; Donadio M; Musella R; Bertetto O; Ciuffreda L; Ferrati P; Clerico M; Calciati A
    Tumori; 1984 Jun; 70(3):237-41. PubMed ID: 6539968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
    González Barón M; Chacón JI; García Girón C; Ordóñez Gallego A; García de Paredes ML; Feliu J; Zamora P; Herranz C; Garrido P; Artal A
    Acta Oncol; 1991; 30(5):623-7. PubMed ID: 1892680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
    Niijima T; Isurugi K; Akaza H; Kondo Y; Kawabe K; Fujita K; Koiso K; Yokoyama M; Kinoshita K; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2376-82. PubMed ID: 3729492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of methylprednisolone and metoclopramide in control of emesis in patients receiving cis-platinum.
    Benrubi GI; Norvell M; Nuss RC; Robinson H
    Gynecol Oncol; 1985 Jul; 21(3):306-13. PubMed ID: 4040050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinnarizine for prevention of nausea and vomiting during platin chemotherapy.
    Wilder-Smith CH; Schimke J; Osterwalder B; Senn HJ
    Acta Oncol; 1991; 30(6):731-4. PubMed ID: 1958394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
    Osoba D; Erlichman C; Willan AR; Levitt M; Pater JL
    Clin Invest Med; 1986 Nov; 9(4):225-31. PubMed ID: 3542325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
    Chevallier B; Cappelaere P; Splinter T; Fabbro M; Wendling JL; Cals L; Catimel G; Giovannini M; Khayat D; Bastit P; Claverie N
    Support Care Cancer; 1997 Jan; 5(1):22-30. PubMed ID: 9010986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained-release metoclopramide plus methylprednisolone versus placebo plus methylprednisolone as antiemetic prophylaxis during non-cisplatin chemotherapy. A randomized double-blind cross-over trial.
    Hansen O; Pfeiffer P; Madsen B; Andersen I; Hansen B; Mathiesen B
    Acta Oncol; 1996; 35(1):57-61. PubMed ID: 8619941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM; Province WS; Perrine GM; Kilgore JR
    Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antiemetics for cisplatin chemotherapy.
    Sridhar KS; Donnelly E
    Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy.
    Tsavaris NB; Koufos C; Katsikas M; Dimitrakopoulos A; Athanasiou E; Linardaki G
    J Pain Symptom Manage; 1999 Sep; 18(3):218-22. PubMed ID: 10517044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
    Bécouarn Y; Nguyen BB; David M; Lakdja F; Brunet R; Chauvergne J
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1421-4. PubMed ID: 3595666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
    Malik IA; Khan WA; Qazilbash M; Ata E; Butt A; Khan MA
    Am J Clin Oncol; 1995 Apr; 18(2):170-5. PubMed ID: 7900711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin.
    Mori K; Saitou Y; Tominaga K; Yokoi ; Miyazawa N
    Eur J Cancer; 1991; 27(6):729-32. PubMed ID: 1648944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
    Clerico M; Bertetto O; Morandini MP; Cardinali C; Giaccone G
    Tumori; 1993 Apr; 79(2):119-22. PubMed ID: 8346563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.